Currently, obtaining Mounjaro in the UK presents a relatively complex landscape. While it's available privately via pharmacy services, NHS access remains limited. Previously, Mounjaro wasn't included on the NHS’s Chronic Disease Management Programme (CDM), but its potential for managing both type

Mounjaro, a innovative medication for managing type 2 diabetes and sometimes obesity, has generated significant interest in the UK. As it stands, availability is limited primarily through private pharmacy services. The expense of Mounjaro can be substantial, typically ranging from around £250